Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation

Garderet, L (author)

Iacobelli, S (author)

Moreau, P (author)

show more...

Dib, M (author)

Caillot, D (author)

Niederwieser, D (author)

Masszi, T (author)

Fontan, J (author)

Michallet, M (author)

Gratwohl, A (author)

Milone, G (author)

Doyen, C (author)

Pegourie, B (author)

Hajek, R (author)

Casassus, P (author)

Kolb, B (author)

Chaleteix, C (author)

Hertenstein, B (author)

Onida, F (author)

Ludwig, H (author)

Vekemans, MC (author)

Ketterer, N (author)

Daguenel, A (author)

Koenecke, C (author)

Gorin, NC (author)

Harousseau, JL (author)

de Witte, T (author)

Morris, C (author)

Gahrton, G (author)

Karolinska Institutet

show less...

 (creator_code:org_t)

2011

2011

English.

In: BONE MARROW TRANSPLANTATION. - 0268-3369. ; 46, s. S3-S3

Related links:

http://kipublication...

• Conference paper (other academic/artistic)